Research at the Department of Internal Medicine

From U of M Internal Medicine Wiki
Jump to navigationJump to search

This page is an index to documentation we have that relates to research. Some pages will show up in multiple sections. For all pages related to research, see Category:Research.

Policies relating to research

Research Groups

Finance documentation related to research

Roles related to research

HR topics related to research

Department Research Interests

 Research Interest
Dr. Alexandra Ilnyckyj
  • Motility and Functional GI disorders
  • Fecal incontinence
  • Therapeutics of IBS
  • Quality assurance pertaining to GI motility
Dr. Allan Garland
  • Epidemiology and long-term outcomes of critical illness
  • Disparities in ICU access
  • Performance improvement, especially the relationships between clinical outcomes and ICU organization/structure
  • End-of-life care
  • Variation in medical practice
  • Statistical modelling methods
Dr. Andrew Halayko
  • lung pathobiology and treatment
Dr. Andrew Maksymiuk
  • Clinical trials in lung cancer, mesothelioma, Head and Neck cancer, upper GI Cancers and Lymphoma
  • Studies of Investigational New Agents in Cancer Treatment
  • Natural Historal Studies: lung cancer, non-Hodgkin's lymphoma, ovarian cancer
  • Case Cluster Investigation - Mesothelioma in Northern Manitoba
Dr. Angela Desautels
  • epidemiology of sleep medicine
  • use of large administrative databases to conduct epidemiological studies within the field of Sleep Medicine
  • influence of chronic illness, medication use and general patient characteristics on sleep quality
  • influence of sleep disorders influence on general health and well-being
Dr. Ashish Shah
  • structural - congenital heart diseases interventions
  • hemodynamics - outcome evaluation in various cardiovascular diseases
Dr. Barret Rush
  • Big Data / Epidemiology
  • Sepsis
  • Mechanical Ventilation Outcomes
  • Palliative care
  • Health disparities / Indigenous Health Outcomes
  • End Stage Liver disease in the Critically Ill
  • Cardiac Arrest
Dr. Bojan Paunovic
  • PROSPECT - Probiotics to prevent severe pneumonia and endotracheal colonization trial
  • HALO - Heparin anticoagulation to improve outcomes in septic shock: The HALO international RCT.
Dr. Carol Hitchon
  • pathogenesis and prognostic indicators in rheumatic diseases, in particular early inflammatory arthritis and systemic lupus erythematosus
Dr. Chantalle MenardQuality Improvement in Healthcare
Dr. Charles Bernstein
  • IBD and Capsule endoscopy
  • IBD epidemiology and outcomes research
  • IBD etiology research
  • optimizing disease diagnostics and prognosticators in IBD
  • clinical trials in IBD and IBS
  • Colorectal cancer screening approaches
Dr. Christine Peschken
  • rheumatic diseases in Indigenous people,
  • systemic lupus erythematosus
Dr. Clara Bohm
  • fully characterizing the benefits of activity promotion and exercise programming in individuals with chronic kidney disease and translating these findings into clinical practice to improve health outcomes
Dr. Clare Ramsey
  • clinical epidemiology of airway diseases
Dr. Claudio Rigatto
  • biomarkers and risk prediction in Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD)
  • development of novel, point-of-care tests for early detection and risk prediction in CKD
Dr. Dana Moffatt
  • ERCP and therapeutic endoscopy
  • ERCP outcomes research
  • ERCP complication prevention research
  • gastrointestinal radiology/gastroenterology interface and endoscopy clinical trials
Dr. David Christiansen
  • pulmonary hypertension
  • pulmonary embolism
  • pulmonary function testing
  • medical education
Dr. David Dawe
  • Treatment patterns and outcomes for frail and elderly patients with cancer
  • Biomarkers of frailty
  • Disparities in cancer treatment by age
  • Lung cancer outcomes
Dr. David SzwajcerDr. Szwajcer has focused his research interests in the areas of regenerative medicine and interprofessional collaboration. These interests link into his clinical and administrative roles as the Manitoba Blood and Marrow Transplant Program Director and the director of the Leukemia and BMT Clinic, CCMB.
Dr. Davinder Jassal
  • noninvasive cardiovascular imaging
Dr. Donald Duerksen
  • Nutrition
  • Celiac disease
  • Nutrition support and home enteral and parenteral nutrition
  • complications of TPN and enteral nutrition
Dr. Eberhard Renner
  • clinical and immunological aspects of liver transplantation.
Dr. Eric BowDr. Bow's research focuses on the prevention and management of bacterial and fungal infections in neutropaenic cancer patients and cytotoxic therapy-induced intestinal epithelial damage in the pathogenesis of these infections. Further, Dr. Bow has been engaged in developing patient-driven hand hygiene compliance monitoring at CancerCare Manitoba. He is active in infection prevention and central strategies in ambulatory career populations. Lastly, he has developed a program for outpatient cancer patient urgent care assessment at CancerCare Manitoba.
Dr. Hani El-Gabalawy
  • pathogenesis and prognosis of early inflammatory arthritis
  • earliest evidence of RA onset in high risk First Nations family members of RA patients
  • research interests centre around the pathogenesis of rheumatoid synovitis
  • the mechanisms involved in the initiation of synovial inflammation
Dr. Harminder Singh
  • Clinical outcomes research
  • Colorectal cancer screening, prevention
  • wait times
  • endoscopy outcomes
  • sedation for colonoscopy
Dr. Ibrahim Abdelgadir< their research interest >
Dr. Isanne SchacterBone, Bariatric Surgery for Type 2 Diabetes
Dr. James Bras< their research interest >
Dr. James JohnstonInvestigating the epidemiology and cellular biology of chronic lymphocytic leukemia, particularly with respect to the mechanism of drug action and the effects of immune-suppression that typify this disease.
Dr. Jeffrey Graham< their research interest >
Dr. Jennifer Salter
  • Acquired brain injury
  • Electrodiagnostic medicine
  • Resident Wellness
  • Resident professionalism
Dr. John Ducas
  • Acute Coronary Syndromes
  • Coronary Atherosclerosis
  • Interventional Cardiology
Dr. John Wilkins
  • the molecular basis of lymphoid cell polarization and movement
Dr. Kelly MacDonald
  • HIV Vaccine Development in the SIV Macaque Model using multi-low dose mucosal challenge, specifically to examine Herpesviruses such as Varicella Zoster Virus (VZV) and Cytomegalovirus (CMV) as lifelong reactivating vectors for HIV vaccine delivery.
Dr. Ken Kasper
  • HIV
  • Infectious Diseases
Dr. Kimberley Mulchey
  • home sleep diagnostics
  • treatment of obstructive sleep apnea
  • epidemiology of sleep related hypoventilation
Dr. Laura Targownik
  • GI bleeding outcomes research
  • Pharmacoepidemiology of proton pump inhibitor use
  • process of care issues regarding the management of gastrointestinal bleeding
  • Prevention of NSAID related gastrointestinal complications.
Dr. Leonard Minuk
  • Clinical trials in oncology, hematology, bone marrow transplantation, and pediatric oncology
Dr. Liam O'Neil
  • the biological events that occur prior to the development of rheumatoid arthritis
  • novel biomarkers that will aid in diagnostic and disease classification, contribute to the understanding of disease pathogenesis, and ultimately improve the quality of life for patients
  • mechanism linking neutrophil extracellular trap (NET) formation and autoantibody responses in rheumatoid arthritis
Dr. Maclean ThiessenDr. Thiessen's research interests include informational support for patients, and shared decision making.
Dr. Marcus Blouw
  • Post-Intensive Care Syndrome
  • Psychological impacts of critical illness
Dr. Marshall PitzOutcomes and effectiveness research; clinical trials in breast cancer and brain tumours. Currently his focus is on pseudoprogression in glioblastoma, health services research and clinical informatics.
Dr. Michael Cantor
  • Endoscopic ultrasound
  • Endoscopic ultrasound outcomes research
  • The role of endoscopic ultrasound in the diagnosis of pancreatic cysts and gastrointestinal subepithelial lesions
Dr. Musawir Ahmed
  • lung transplant medicine
Dr. Navdeep Tangri
  • improving clinical decision making for patients with advanced chronic kidney disease
  • frailty, physical and cognitive function in advanced CKD
  • safety and efficacy of a new therapy for CKD
Dr. Pamela Katz
  • Familial hypercholesterolemia
  • Cardiovascular clinical trials in individuals with Diabetes
  • Diabetes and lipid disorders
Dr. Paul Komenda
  • Chronic Kidney Disease
  • Health Economics
  • Health Outcomes
  • Home Hemodialysis
  • Nephrology
  • Epidemiology and Biostatistics
Dr. Philip St. John• Epidemiology of Ageing

• Epidemiology of Functional Decline • Cohort Studies

• Ageing in rural areas
Dr. Ruth Ann Marrie
  • the influence of comorbid factors, such as other chronic diseases, health behaviours, and critical illness on a range of multiple sclerosis (MS)-related health outcomes
  • etiologic factors for MS
  • patient-reported outcomes
  • pediatric MS
Dr. Ryan Skrabek
  • Pain Management
  • Amputee Rehabilitation
Dr. Stephen Corne
  • Physiology of central and obstructive sleep apnea
  • Non-invasive ventilation in neuro-muscular diseases
Dr. Stephen WongViral Hepatitis, Fatty Liver, Medical Education
Dr. Susan Green•Thoracic Oncology •Medical Education
Dr. Versha BanerjiAs a clinical scientist my goal is to bring effective and tolerable treatments to patients with blood cancers. My research program aims to target dependency on metabolism in cancer. Many novel agents are being developed and combined with excellent efficacy but challenges with tolerability. In addition, novel agents are entering clinical practice and we are now seeing resistance arise in the most effective treatments. Many of the resistance patterns are secondary to increases oxidative phosphorylation as the survival mechanism of these cells. My program focuses on the evaluation of small molecules or approved compounds on mitochondrial metabolism in cancer cells using primary cells or cell lines models using a suspension-based method to evaluation oxygen consumption. With this platform we aim to identify candidates compounds to move from pre-clinical to in vivo testing. We design combination therapies and evaluate dose reduction strategies in vitro and ex vivo.

Related articles

Related articles: